12 Health Care Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • MediciNova MNOV stock rose 88.38% to $10.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $521.8 million.
  • Obalon Therapeutics OBLN stock moved upwards by 33.61% to $4.73. The market value of their outstanding shares is at $36.7 million.
  • Atossa Therapeutics ATOS shares moved upwards by 21.77% to $3.02. The market value of their outstanding shares is at $216.1 million.
  • Artelo Biosciences ARTL shares rose 20.69% to $2.25. The market value of their outstanding shares is at $35.2 million.
  • ChromaDex CDXC stock increased by 17.8% to $13.5. The market value of their outstanding shares is at $894.0 million. As per the press release, Q4 earnings came out today.
  • Affimed AFMD shares rose 13.34% to $6.2. The market value of their outstanding shares is at $711.6 million.

 

 

Losers

 

  • INVO Bioscience INVO stock decreased by 15.0% to $7.99 during Wednesday's pre-market session. The market value of their outstanding shares is at $76.3 million.
  • AnPac Bio-Medical Science ANPC shares fell 10.34% to $7.72. The company's market cap stands at $86.4 million.
  • Cue Biopharma CUE stock decreased by 8.38% to $13.02. The market value of their outstanding shares is at $394.2 million. As per the news, the Q4 earnings report came out yesterday.
  • Brickell Biotech BBI shares decreased by 8.2% to $1.12. The market value of their outstanding shares is at $59.9 million. As per the news, the Q4 earnings report came out yesterday.
  • Second Sight Medical EYES stock declined by 7.82% to $14.27. The company's market cap stands at $331.2 million.
  • OpGen OPGN stock fell 7.55% to $2.82. The company's market cap stands at $78.5 million.

 

 

Market News and Data brought to you by Benzinga APIs
Posted In: Pre-Market OutlookMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...